Style | Citing Format |
---|---|
MLA | Ahmadi SB, et al.. "Bupropion Showed Neuroprotective Impacts Against Cerebral Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation." Iranian Journal of Pharmaceutical Research, vol. 23, no. 1, 2025, pp. -. |
APA | Ahmadi SB, Khalilabad ZA, Alemohammad SS, Manesh HY, Abdollahi A, Jazayeri F, Mousavi SE (2025). Bupropion Showed Neuroprotective Impacts Against Cerebral Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation. Iranian Journal of Pharmaceutical Research, 23(1), -. |
Chicago | Ahmadi SB, Khalilabad ZA, Alemohammad SS, Manesh HY, Abdollahi A, Jazayeri F, Mousavi SE. "Bupropion Showed Neuroprotective Impacts Against Cerebral Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation." Iranian Journal of Pharmaceutical Research 23, no. 1 (2025): -. |
Harvard | Ahmadi SB et al. (2025) 'Bupropion Showed Neuroprotective Impacts Against Cerebral Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation', Iranian Journal of Pharmaceutical Research, 23(1), pp. -. |
Vancouver | Ahmadi SB, Khalilabad ZA, Alemohammad SS, Manesh HY, Abdollahi A, Jazayeri F, et al.. Bupropion Showed Neuroprotective Impacts Against Cerebral Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation. Iranian Journal of Pharmaceutical Research. 2025;23(1):-. |
BibTex | @article{ author = {Ahmadi SB and Khalilabad ZA and Alemohammad SS and Manesh HY and Abdollahi A and Jazayeri F and Mousavi SE}, title = {Bupropion Showed Neuroprotective Impacts Against Cerebral Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation}, journal = {Iranian Journal of Pharmaceutical Research}, volume = {23}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Ahmadi SB AU - Khalilabad ZA AU - Alemohammad SS AU - Manesh HY AU - Abdollahi A AU - Jazayeri F AU - Mousavi SE TI - Bupropion Showed Neuroprotective Impacts Against Cerebral Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation JO - Iranian Journal of Pharmaceutical Research VL - 23 IS - 1 SP - EP - PY - 2025 ER - |